Newsroom

Industry News

21 Oct

Inovio Pharmaceuticals, MedImmune and the University of Pennsylvania Partner to Combat Influenza and Antibiotic Resistant Bacteria

 Inovio Pharmaceuticals, Inc. (INO) announced today the Defense Advanced Research Projects Agency (DARPA) has awarded $12.2 million for a collaborative study that will be conducted by scientists from the Perelman School of Medicine at the University of Pennsylvania; Inovio Pharmaceuticals; and MedImmune, the global biologics research and development arm...

Read more

20 Oct

Matinas BioPharma Submits Investigational New Drug Application for Lead Product Candidate MAT9001 for the Treatment of Severe Hypertriglyceridemia

Matinas BioPharma Holdings, Inc.(“Matinas BioPharma” or the “Company”) (MTNB), an emerging biopharmaceutical company focused on the development and commercialization of omega-3 fatty acid-based prescription therapeutics for the treatment of cardiovascular and metabolic conditions, announced today that the Company has submitted an Investigational New Drug application (IND) for MAT9001 to...

Read more

17 Oct

Harvard Apparatus Regenerative Technology Updates Patient Status

Harvard Apparatus Regenerative Technology, Inc. (HART), or HART, a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, has recently been informed by the principal investigator in the Russian regenerated trachea transplant studies in which it is taking part that one of the patients...

Read more

17 Oct

Athersys to Host Third Quarter 2014 Financial Results Call

Athersys, Inc. (ATHX) will release its third quarter 2014 financial results at approximately 4:00 PM (Eastern Time) on Monday, November 10, 2014, and host a conference call shortly thereafter at 4:30 PM (Eastern Time) to review the results. Gil Van Bokkelen, Chairman and Chief Executive Officer, and William (B.J.)...

Read more

16 Oct

NXT-ID Inc. to Present at 13th Annual FiRe Conference

FiRe – “The best technology conference in the world” – The Economist NXT-ID, Inc. (NASDAQ:NXTD and NXTDW) (“NXT-ID” or the “Company”), a biometric authentication company focused on the growing mobile commerce market announces that it will present its leading edge technologies including Wocket™, the Smart Wallet, at the 13th annual...

Read more

16 Oct

Intellipharmaceutics Announces Third Quarter 2014 Results

Intellipharmaceutics International Inc.(IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today reported the results of operations for the three and nine months ended August 31, 2014. All dollar amounts referenced herein are in United...

Read more

15 Oct

Princeton University Acquires Protea’s LAESI(R) Technology Platform

LAESI Direct Molecular Analysis Platform to be Used in Antimicrobial Research Protea Biosciences Group, Inc. (PRGB) (“Protea”) announced today that Princeton University has purchased Protea’s LAESI DP-1000 Instrument System for direct molecular analysis. The system will be used in Princeton’s Frick Chemistry Laboratory for the screening of microbial samples...

Read more

Page 1 of 2312345...1020...Last »

Latest Tweets